IVSBF (IVSBF) Stock Price & Analysis
IVSBF (IVSBF) rose 3.37% to USD 41.09 as of June 10, 2026 at 00:44 UTC, according to Nexqual real-time market data.
IVSBF last closed at USD 39.75; the session ranged USD 41.09–41.09 on volume of 3 shares. Market capitalization is $125.89B, with a 52-week range of USD 27.79–42.36 (PNK). Source: Nexqual, June 10, 2026 at 00:44 UTC.
Key Statistics (as of June 10, 2026 at 00:44 UTC)
| Price | USD 41.09 |
|---|---|
| Change | ▲ 3.37% (up) |
| Previous Close | USD 39.75 |
| Open | USD 41.09 |
| Day Range | USD 41.09 – 41.09 |
| 52-Week Range | USD 27.79 – 42.36 |
| Volume | 3 shares |
| Market Cap | $125.89B |
| Exchange | PNK |
Technical Analysis (IVSBF)
Nexqual's technical model rates IVSBF "SELL" based on 2 bullish and 4 bearish signals across 123 daily candles, as of June 10, 2026 at 00:44 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.26 (neutral) |
| vs SMA50 | Above (USD 39.95) |
| MACD | 0.05 (positive) |
Analyst Ratings (IVSBF)
Wall Street analysts rate IVSBF "None", per Nexqual as of June 10, 2026 at 00:44 UTC.
| Consensus Rating | None |
|---|
Earnings (IVSBF)
Source: Nexqual, June 10, 2026 at 00:44 UTC.
Financials & Fundamentals (IVSBF)
| Revenue Growth (YoY) | +357.30% |
|---|---|
| Gross Margin | +86.77% |
| Operating Margin | +0.00% |
| Profit Margin | +74.52% |
| ROE | +21.20% |
| Debt / Equity | 12.4 |
| Current Ratio | 3.51 |
| Free Cash Flow | $126.12B |
Source: Nexqual, June 10, 2026 at 00:44 UTC.
Financial Health Score (IVSBF)
Nexqual rates IVSBF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:44 UTC.
| Growth | Critical — Revenue -14% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Gross margin 87%, operating 0% |
| Balance Sheet | Strong — Debt/Equity 0.1x |
| Cash Flow | Strong — FCF $126.1B, 195% margin |
| Efficiency | Strong — ROE 21%, ROA 11.9% |
Ownership (IVSBF)
| Insider Ownership | +0.25% |
|---|---|
| Institutional Ownership | +50.09% |
| Shares Outstanding | 1.82B |
| Float | 2.44B |
Source: Nexqual, June 10, 2026 at 00:44 UTC.
Leadership (IVSBF)
IVSBF is led by Christian Cederholm (age 47), President, CEO, Director & Member of Management Board, per Nexqual as of June 10, 2026 at 00:44 UTC.
| President, CEO, Director & Member of Management Board | Christian Cederholm (age 47) |
|---|---|
| Chief Financial Officer | Jenny Ashman Haquinius (age 39) |
Major Backers & Investors (IVSBF)
Notable institutional backers of IVSBF include Fidelity, First Eagle Funds-First Eagle Global Fund, according to Nexqual as of June 10, 2026 at 00:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 1.56% |
| First Eagle Funds-First Eagle Global Fund | 0.97% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.28% |
| BlackRock | 1.07% |
Source: Nexqual, June 10, 2026 at 00:44 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IVSXF | Investors AB | USD 40.05 | ▼ 0.89% |
| AXAHF | AXA | USD 46.7 | ▲ 1.52% |
| ZFSVF | Zurich Insurance Group Ltd | USD 694.09 | ▼ 0% |
| TGOPF | 3i Group Plc", | USD 30.89 | ▲ 3.66% |
| SHECF | Shin-Etsu Chemical Co., Ltd. | USD 46.5 | ▲ 7.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:44 UTC. This page is informational and not investment advice.